To the content
1 . 2014

Antiretroviral therapy and therapy of chronic hepatitis С in HIV-infected patients

Abstract

Modern regimens of antiretroviral therapy can significantly improve the lifetime and quality of life of patients with co-infection HIV/HCV. Therefore, the appointment of the treatment of HIV infection and chronic hepatitis C should consider the likelihood drug-drug interactions, sex and age characteristics of the patients and the presence of comorbidities. Available drugs in the arsenal of the physician can not only take into account the characteristics and the risks of developing of adverse events for a patient, but also to minimize hepatotoxic, nephrotoxic and possibly neurotoxic effects of drugs.

Keywords:HIV infection, chronic hepatitis С, antiretroviral therapy, hepatotoxicity

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)
Journals of «GEOTAR-Media»